Dr. Scharre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
Fl 3
Columbus, OH 43221Phone+1 614-293-4969Fax+1 614-293-6111
Education & Training
- Letterman Army Medical CenterResidency, Neurology, 1984 - 1987
- William Beaumont Army Medical CenterInternship, Internal Medicine, 1983 - 1984
- Georgetown University School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1985 - Present
- OH State Medical License 1993 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31
- Efficacy and Safety of MMFS in Early AD Start of enrollment: 2018 Mar 20
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsSelf-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.Douglas W Scharre, Shu Ing Chang, Haikady N Nagaraja, Natalie C Wheeler, Maria Kataki
Alzheimer's Research & Therapy. 2021-12-06 - 18 citationsCommunity Cognitive Screening Using the Self-Administered Gerocognitive Examination (SAGE).Douglas W. Scharre, Shu ing Chang, Haikady N. Nagaraja, Jennifer Yager-Schweller, Robert A. Murden
The Journal of Neuropsychiatry and Clinical Neurosciences. 2014-01-01 - 734 citationsEarly role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysisYasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
Press Mentions
- Q&A: Self-Administered Tool Significantly Improves Cognitive Impairment DetectionAugust 9th, 2024
- This 1 Dementia Symptom May Appear Years Before Memory LossJuly 30th, 2024
- New Drug Shows Slowing in Cognitive Decline in Patients with Alzheimer's DiseaseMay 7th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: